These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8730942)

  • 1. A controlled trial of dothiepin and placebo in treating benzodiazepine withdrawal symptoms.
    Tyrer P; Ferguson B; Hallström C; Michie M; Tyrer S; Cooper S; Caplan R; Barczak P
    Br J Psychiatry; 1996 Apr; 168(4):457-61. PubMed ID: 8730942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
    Kornowski J
    Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
    Mahapatra SN; Hackett D
    Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, comparative study of dothiepin and clomipramine in the treatment of major depressive illness.
    Welch CP; Tweed JA; Smithers A; Gostick NK; Raniwalla J
    Int J Clin Pract; 1997 Sep; 51(6):360-3. PubMed ID: 9489063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dothiepin versus doxepin in major depression: results of a multicenter, placebo-controlled trial. Prothiaden Collaborative Study Group.
    Ferguson JM; Mendels J; Manowitz NR
    J Clin Psychiatry; 1994 Jun; 55(6):258-63. PubMed ID: 8071282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence.
    Murphy SM; Tyrer P
    Br J Psychiatry; 1991 Apr; 158():511-6. PubMed ID: 1675901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Olajide D
    J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings.
    Denis C; Fatséas M; Lavie E; Auriacombe M
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005194. PubMed ID: 16856084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions.
    Linden M; Bär T; Geiselmann B
    Psychol Med; 1998 May; 28(3):721-9. PubMed ID: 9626728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial.
    Petrovic M; Pevernagie D; Mariman A; Van Maele G; Afschrift M
    Eur J Clin Pharmacol; 2002 Jan; 57(11):759-64. PubMed ID: 11868796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
    Romach MK; Kaplan HL; Busto UE; Somer G; Sellers EM
    J Clin Psychopharmacol; 1998 Apr; 18(2):121-31. PubMed ID: 9555597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine withdrawal effects.
    Pecknold JC; McClure DJ; Fleuri D; Chang H
    Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):517-22. PubMed ID: 6131488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dothiepin on subjects with rheumatoid arthritis and depression.
    Ash G; Dickens CM; Creed FH; Jayson MI; Tomenson B
    Rheumatology (Oxford); 1999 Oct; 38(10):959-67. PubMed ID: 10534546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Benzodiazepine withdrawal with carbamazepine].
    Kaendler SH; Volk S; Pflug B
    Nervenarzt; 1996 May; 67(5):381-6. PubMed ID: 9005346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy, safety and withdrawal of alpidem and alprazolam in anxious patients.
    Frattola L; Garreau M; Piolti R; Bassi S; Albizzati MG; Borghi C; Morselli PL
    Br J Psychiatry; 1994 Jul; 165(1):94-100. PubMed ID: 7802852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG; Guelfi JD; Comet D
    Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluoxetine and dothiepin on 24-hour activity in depressed patients.
    Stanley N; Fairweather DB; Hindmarch I
    Neuropsychobiology; 1999; 39(1):44-8. PubMed ID: 9892859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.